{"id":"W4233331803","doi":"10.4081/oncol.2008.67","title":"The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia","year":2011,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Imatinib; Imatinib mesylate; LYN; Nilotinib; Tyrosine kinase; Tolerability; Tyrosine-kinase inhibitor; Pharmacology; Leukemia; Cancer research; Internal medicine; Myeloid leukemia; Adverse effect; Receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006617138,0.0001420483,0.0003031346,0.0003377656,0.0001701615,0.0005432449,0.0001819421,0.0005642599,0.00112489],"category_scores_gemma":[0.0008056808,0.00008199115,0.0001488879,0.0003256596,0.0005084545,0.0005129282,0.0002795223,0.0006997135,0.00028833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004596896,"about_ca_system_score_gemma":0.0004592814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005897752,"about_ca_topic_score_gemma":0.001071009,"domain_scores_codex":[0.9998274,0.00005922204,0.00001937444,0.00001924744,0.00004979563,0.00002488612],"domain_scores_gemma":[0.999765,0.0001162791,0.00006333353,0.00000497171,0.00003250476,0.00001796275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008716995,0.0001735397,0.007390116,0.002661005,0.0001074473,0.001938023,0.0004055685,0.0009367805,0.0191784,0.01615115,0.02556932,0.924617],"study_design_scores_gemma":[0.0005530525,0.002911409,0.09822335,0.003893866,0.0005245847,0.02081472,0.000918161,0.001897296,0.01629438,0.02301953,0.8308516,0.00009802621],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01911807,0.9694766,0.000180033,0.005164179,0.0002837093,0.000005911566,0.00002278111,0.000005984799,0.005742737],"genre_scores_gemma":[0.1595093,0.8356928,0.0002365628,0.001076207,0.001233211,0.0000125054,0.00002662108,0.000002382758,0.002210396],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00112489,"threshold_uncertainty_score":0.003763139,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05150534616313029,"score_gpt":0.3226476964549519,"score_spread":0.2711423502918216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}